3.26.1 html 351 350 1 true 120 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://biolargo.com/20260331/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) Sheet http://biolargo.com/20260331/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited Condensed Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://biolargo.com/20260331/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://biolargo.com/20260331/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://biolargo.com/20260331/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parentheticals) Sheet http://biolargo.com/20260331/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited-parentheticals Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parentheticals) Statements 6 false false R7.htm 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://biolargo.com/20260331/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 007 - Disclosure - Note 1 - Business and Organization Sheet http://biolargo.com/20260331/role/statement-note-1-business-and-organization Note 1 - Business and Organization Notes 8 false false R9.htm 008 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://biolargo.com/20260331/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 9 false false R10.htm 009 - Disclosure - Note 3 - Sale of Stock for Cash Sheet http://biolargo.com/20260331/role/statement-note-3-sale-of-stock-for-cash Note 3 - Sale of Stock for Cash Notes 10 false false R11.htm 010 - Disclosure - Note 4 - Debt Obligations Sheet http://biolargo.com/20260331/role/statement-note-4-debt-obligations Note 4 - Debt Obligations Notes 11 false false R12.htm 011 - Disclosure - Note 5 - Share-based Compensation Sheet http://biolargo.com/20260331/role/statement-note-5-sharebased-compensation Note 5 - Share-based Compensation Notes 12 false false R13.htm 012 - Disclosure - Note 6 - Warrants Sheet http://biolargo.com/20260331/role/statement-note-6-warrants Note 6 - Warrants Notes 13 false false R14.htm 013 - Disclosure - Note 7 - Accounts Payable and Accrued Expenses Sheet http://biolargo.com/20260331/role/statement-note-7-accounts-payable-and-accrued-expenses Note 7 - Accounts Payable and Accrued Expenses Notes 14 false false R15.htm 014 - Disclosure - Note 8 - Noncontrolling Interest - Clyra Medical Sheet http://biolargo.com/20260331/role/statement-note-8-noncontrolling-interest-clyra-medical Note 8 - Noncontrolling Interest - Clyra Medical Notes 15 false false R16.htm 015 - Disclosure - Note 9 - BioLargo Engineering, Science and Technologies, LLC Sheet http://biolargo.com/20260331/role/statement-note-9-biolargo-engineering-science-and-technologies-llc Note 9 - BioLargo Engineering, Science and Technologies, LLC Notes 16 false false R17.htm 016 - Disclosure - Note 10 - BioLargo Energy Technologies, Inc. Sheet http://biolargo.com/20260331/role/statement-note-10-biolargo-energy-technologies-inc Note 10 - BioLargo Energy Technologies, Inc. Notes 17 false false R18.htm 017 - Disclosure - Note 11 - Business Segment Information Sheet http://biolargo.com/20260331/role/statement-note-11-business-segment-information Note 11 - Business Segment Information Notes 18 false false R19.htm 018 - Disclosure - Note 12 - Leases Sheet http://biolargo.com/20260331/role/statement-note-12-leases Note 12 - Leases Notes 19 false false R20.htm 019 - Disclosure - Note 13 - Legal Proceedings Sheet http://biolargo.com/20260331/role/statement-note-13-legal-proceedings Note 13 - Legal Proceedings Notes 20 false false R21.htm 020 - Disclosure - Note 14 - Subsequent Events Sheet http://biolargo.com/20260331/role/statement-note-14-subsequent-events Note 14 - Subsequent Events Notes 21 false false R22.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 22 false false R23.htm 995467 - Disclosure - Significant Accounting Policies (Policies) Sheet http://biolargo.com/20260331/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://biolargo.com/20260331/role/statement-note-2-summary-of-significant-accounting-policies 23 false false R24.htm 995468 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) Sheet http://biolargo.com/20260331/role/statement-note-2-summary-of-significant-accounting-policies-tables Note 2 - Summary of Significant Accounting Policies (Tables) Tables http://biolargo.com/20260331/role/statement-note-2-summary-of-significant-accounting-policies 24 false false R25.htm 995469 - Disclosure - Note 4 - Debt Obligations (Tables) Sheet http://biolargo.com/20260331/role/statement-note-4-debt-obligations-tables Note 4 - Debt Obligations (Tables) Tables http://biolargo.com/20260331/role/statement-note-4-debt-obligations 25 false false R26.htm 995470 - Disclosure - Note 5 - Share-based Compensation (Tables) Sheet http://biolargo.com/20260331/role/statement-note-5-sharebased-compensation-tables Note 5 - Share-based Compensation (Tables) Tables http://biolargo.com/20260331/role/statement-note-5-sharebased-compensation 26 false false R27.htm 995471 - Disclosure - Note 6 - Warrants (Tables) Sheet http://biolargo.com/20260331/role/statement-note-6-warrants-tables Note 6 - Warrants (Tables) Tables http://biolargo.com/20260331/role/statement-note-6-warrants 27 false false R28.htm 995472 - Disclosure - Note 7 - Accounts Payable and Accrued Expenses (Tables) Sheet http://biolargo.com/20260331/role/statement-note-7-accounts-payable-and-accrued-expenses-tables Note 7 - Accounts Payable and Accrued Expenses (Tables) Tables http://biolargo.com/20260331/role/statement-note-7-accounts-payable-and-accrued-expenses 28 false false R29.htm 995473 - Disclosure - Note 8 - Noncontrolling Interest - Clyra Medical (Tables) Sheet http://biolargo.com/20260331/role/statement-note-8-noncontrolling-interest-clyra-medical-tables Note 8 - Noncontrolling Interest - Clyra Medical (Tables) Tables http://biolargo.com/20260331/role/statement-note-8-noncontrolling-interest-clyra-medical 29 false false R30.htm 995474 - Disclosure - Note 11 - Business Segment Information (Tables) Sheet http://biolargo.com/20260331/role/statement-note-11-business-segment-information-tables Note 11 - Business Segment Information (Tables) Tables http://biolargo.com/20260331/role/statement-note-11-business-segment-information 30 false false R31.htm 995475 - Disclosure - Note 12 - Leases (Tables) Sheet http://biolargo.com/20260331/role/statement-note-12-leases-tables Note 12 - Leases (Tables) Tables http://biolargo.com/20260331/role/statement-note-12-leases 31 false false R32.htm 995476 - Disclosure - Note 1 - Business and Organization (Details Textual) Sheet http://biolargo.com/20260331/role/statement-note-1-business-and-organization-details-textual Note 1 - Business and Organization (Details Textual) Details http://biolargo.com/20260331/role/statement-note-1-business-and-organization 32 false false R33.htm 995477 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://biolargo.com/20260331/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Details http://biolargo.com/20260331/role/statement-note-2-summary-of-significant-accounting-policies-tables 33 false false R34.htm 995478 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Summary of Cash Balances (Details) Sheet http://biolargo.com/20260331/role/statement-note-2-summary-of-significant-accounting-policies-summary-of-cash-balances-details Note 2 - Summary of Significant Accounting Policies - Summary of Cash Balances (Details) Details 34 false false R35.htm 995479 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Credit Concentration (Details) Sheet http://biolargo.com/20260331/role/statement-note-2-summary-of-significant-accounting-policies-credit-concentration-details Note 2 - Summary of Significant Accounting Policies - Credit Concentration (Details) Details 35 false false R36.htm 995480 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Inventory (Details) Sheet http://biolargo.com/20260331/role/statement-note-2-summary-of-significant-accounting-policies-inventory-details Note 2 - Summary of Significant Accounting Policies - Inventory (Details) Details http://biolargo.com/20260331/role/statement-note-2-summary-of-significant-accounting-policies-tables 36 false false R37.htm 995481 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Other Non-current Assets (Details) Sheet http://biolargo.com/20260331/role/statement-note-2-summary-of-significant-accounting-policies-other-noncurrent-assets-details Note 2 - Summary of Significant Accounting Policies - Other Non-current Assets (Details) Details 37 false false R38.htm 995482 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Stock Options, Valuation Assumptions (Details) Sheet http://biolargo.com/20260331/role/statement-note-2-summary-of-significant-accounting-policies-stock-options-valuation-assumptions-details Note 2 - Summary of Significant Accounting Policies - Stock Options, Valuation Assumptions (Details) Details 38 false false R39.htm 995483 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Schedule of Equipment and Leasehold Improvements (Details) Sheet http://biolargo.com/20260331/role/statement-note-2-summary-of-significant-accounting-policies-schedule-of-equipment-and-leasehold-improvements-details Note 2 - Summary of Significant Accounting Policies - Schedule of Equipment and Leasehold Improvements (Details) Details 39 false false R40.htm 995484 - Disclosure - Note 3 - Sale of Stock for Cash (Details Textual) Sheet http://biolargo.com/20260331/role/statement-note-3-sale-of-stock-for-cash-details-textual Note 3 - Sale of Stock for Cash (Details Textual) Details http://biolargo.com/20260331/role/statement-note-3-sale-of-stock-for-cash 40 false false R41.htm 995485 - Disclosure - Note 4 - Debt Obligations (Details Textual) Sheet http://biolargo.com/20260331/role/statement-note-4-debt-obligations-details-textual Note 4 - Debt Obligations (Details Textual) Details http://biolargo.com/20260331/role/statement-note-4-debt-obligations-tables 41 false false R42.htm 995486 - Disclosure - Note 4 - Debt Obligations - Schedule of Debt (Details) Sheet http://biolargo.com/20260331/role/statement-note-4-debt-obligations-schedule-of-debt-details Note 4 - Debt Obligations - Schedule of Debt (Details) Details 42 false false R43.htm 995487 - Disclosure - Note 5 - Share-based Compensation (Details Textual) Sheet http://biolargo.com/20260331/role/statement-note-5-sharebased-compensation-details-textual Note 5 - Share-based Compensation (Details Textual) Details http://biolargo.com/20260331/role/statement-note-5-sharebased-compensation-tables 43 false false R44.htm 995488 - Disclosure - Note 5 - Share-based Compensation - Stock Options (Details) Sheet http://biolargo.com/20260331/role/statement-note-5-sharebased-compensation-stock-options-details Note 5 - Share-based Compensation - Stock Options (Details) Details 44 false false R45.htm 995489 - Disclosure - Note 6 - Warrants (Details Textual) Sheet http://biolargo.com/20260331/role/statement-note-6-warrants-details-textual Note 6 - Warrants (Details Textual) Details http://biolargo.com/20260331/role/statement-note-6-warrants-tables 45 false false R46.htm 995490 - Disclosure - Note 6 - Warrants - Warrants Outstanding (Details) Sheet http://biolargo.com/20260331/role/statement-note-6-warrants-warrants-outstanding-details Note 6 - Warrants - Warrants Outstanding (Details) Details 46 false false R47.htm 995491 - Disclosure - Note 6 - Warrants - Assumptions Used to Determine Fair Value of Warrants (Details) Sheet http://biolargo.com/20260331/role/statement-note-6-warrants-assumptions-used-to-determine-fair-value-of-warrants-details Note 6 - Warrants - Assumptions Used to Determine Fair Value of Warrants (Details) Details 47 false false R48.htm 995492 - Disclosure - Note 7 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) Sheet http://biolargo.com/20260331/role/statement-note-7-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details Note 7 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) Details 48 false false R49.htm 995493 - Disclosure - Note 8 - Noncontrolling Interest - Clyra Medical (Details Textual) Sheet http://biolargo.com/20260331/role/statement-note-8-noncontrolling-interest-clyra-medical-details-textual Note 8 - Noncontrolling Interest - Clyra Medical (Details Textual) Details http://biolargo.com/20260331/role/statement-note-8-noncontrolling-interest-clyra-medical-tables 49 false false R50.htm 995494 - Disclosure - Note 8 - Noncontrolling Interest - Clyra Medical - Common Shares Outstanding (Details) Sheet http://biolargo.com/20260331/role/statement-note-8-noncontrolling-interest-clyra-medical-common-shares-outstanding-details Note 8 - Noncontrolling Interest - Clyra Medical - Common Shares Outstanding (Details) Details 50 false false R51.htm 995495 - Disclosure - Note 8 - Noncontrolling Interest - Clyra Medical - Valuation Assumptions (Details) Sheet http://biolargo.com/20260331/role/statement-note-8-noncontrolling-interest-clyra-medical-valuation-assumptions-details Note 8 - Noncontrolling Interest - Clyra Medical - Valuation Assumptions (Details) Details 51 false false R52.htm 995496 - Disclosure - Note 8 - Noncontrolling Interest - Clyra Medical - Warrants Outstanding (Details) Sheet http://biolargo.com/20260331/role/statement-note-8-noncontrolling-interest-clyra-medical-warrants-outstanding-details Note 8 - Noncontrolling Interest - Clyra Medical - Warrants Outstanding (Details) Details 52 false false R53.htm 995497 - Disclosure - Note 8 - Noncontrolling Interest - Clyra Medical - Summary of Accounts Payable and Accrued Expenses (Details) Sheet http://biolargo.com/20260331/role/statement-note-8-noncontrolling-interest-clyra-medical-summary-of-accounts-payable-and-accrued-expenses-details Note 8 - Noncontrolling Interest - Clyra Medical - Summary of Accounts Payable and Accrued Expenses (Details) Details 53 false false R54.htm 995498 - Disclosure - Note 8 - Noncontrolling Interest - Clyra Medical - Schedule of Lease Maturity (Details) Sheet http://biolargo.com/20260331/role/statement-note-8-noncontrolling-interest-clyra-medical-schedule-of-lease-maturity-details Note 8 - Noncontrolling Interest - Clyra Medical - Schedule of Lease Maturity (Details) Details 54 false false R55.htm 995499 - Disclosure - Note 9 - BioLargo Engineering, Science and Technologies, LLC (Details Textual) Sheet http://biolargo.com/20260331/role/statement-note-9-biolargo-engineering-science-and-technologies-llc-details-textual Note 9 - BioLargo Engineering, Science and Technologies, LLC (Details Textual) Details http://biolargo.com/20260331/role/statement-note-9-biolargo-engineering-science-and-technologies-llc 55 false false R56.htm 995500 - Disclosure - Note 10 - BioLargo Energy Technologies, Inc. (Details Textual) Sheet http://biolargo.com/20260331/role/statement-note-10-biolargo-energy-technologies-inc-details-textual Note 10 - BioLargo Energy Technologies, Inc. (Details Textual) Details http://biolargo.com/20260331/role/statement-note-10-biolargo-energy-technologies-inc 56 false false R57.htm 995501 - Disclosure - Note 11 - Business Segment Information (Details Textual) Sheet http://biolargo.com/20260331/role/statement-note-11-business-segment-information-details-textual Note 11 - Business Segment Information (Details Textual) Details http://biolargo.com/20260331/role/statement-note-11-business-segment-information-tables 57 false false R58.htm 995502 - Disclosure - Note 11 - Business Segment Information - Segment Information (Details) Sheet http://biolargo.com/20260331/role/statement-note-11-business-segment-information-segment-information-details Note 11 - Business Segment Information - Segment Information (Details) Details 58 false false R59.htm 995503 - Disclosure - Note 12 - Leases (Details Textual) Sheet http://biolargo.com/20260331/role/statement-note-12-leases-details-textual Note 12 - Leases (Details Textual) Details http://biolargo.com/20260331/role/statement-note-12-leases-tables 59 false false R60.htm 995504 - Disclosure - Note 12 - Leases - Schedule of Future Minimum Lease Payments (Details) Sheet http://biolargo.com/20260331/role/statement-note-12-leases-schedule-of-future-minimum-lease-payments-details Note 12 - Leases - Schedule of Future Minimum Lease Payments (Details) Details 60 false false R61.htm 995505 - Disclosure - Note 13 - Legal Proceedings (Details Textual) Sheet http://biolargo.com/20260331/role/statement-note-13-legal-proceedings-details-textual Note 13 - Legal Proceedings (Details Textual) Details http://biolargo.com/20260331/role/statement-note-13-legal-proceedings 61 false false R62.htm 995506 - Disclosure - Note 14 - Subsequent Events (Details Textual) Sheet http://biolargo.com/20260331/role/statement-note-14-subsequent-events-details-textual Note 14 - Subsequent Events (Details Textual) Details http://biolargo.com/20260331/role/statement-note-14-subsequent-events 62 false false All Reports Book All Reports blgo-20260331.xsd blgo-20260331_cal.xml blgo-20260331_def.xml blgo-20260331_lab.xml blgo-20260331_pre.xml blgo20260331_10q.htm http://fasb.org/us-gaap/2026 http://xbrl.sec.gov/dei/2026 http://xbrl.sec.gov/ecd/2026 true true